| Q38207936 | Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases |
| Q36355165 | Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia |
| Q35699115 | Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy |
| Q27027039 | Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond |
| Q35701236 | Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice |
| Q33748680 | Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity |
| Q33748650 | Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia |
| Q33765684 | Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients |
| Q24605647 | Angiotensin receptors, autoimmunity, and preeclampsia |
| Q37307973 | Are we getting closer to a Nobel prize for unraveling preeclampsia? |
| Q34618522 | Association between the presence of autoantibodies against adrenoreceptors and severe pre-eclampsia: a pilot study |
| Q37348150 | Association of autoantibodies against the M2-muscarinic receptor with perinatal outcomes in women with severe preeclampsia |
| Q37436219 | Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats |
| Q35681804 | Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling |
| Q35715914 | Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia |
| Q36050771 | Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling |
| Q34040357 | Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia |
| Q36836373 | Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia |
| Q33577570 | Endothelial dysfunction induced by antibodies against angiotensin AT1 receptor in immunized rats |
| Q36268948 | Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy |
| Q37786350 | Immunologic characteristics of preeclampsia, a comprehensive review |
| Q36050775 | Is preeclampsia an autoimmune disease? |
| Q38543831 | Linking the old and new -- do angiotensin II type 1 receptor antibodies provide the missing link in the pathophysiology of preeclampsia? |
| Q36577103 | Mechanisms of disease: Pre-eclampsia |
| Q33349894 | Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia |
| Q37022723 | Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction |
| Q37114991 | Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections |
| Q35681821 | Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia |
| Q26746841 | Pre-eclampsia: its pathogenesis and pathophysiolgy |
| Q38889590 | Preeclampsia and the brain: neural control of cardiovascular changes during pregnancy and neurological outcomes of preeclampsia |
| Q26800272 | Preeclampsia: long-term consequences for vascular health |
| Q42701351 | Progress toward identifying potential markers for preeclampsia: role of agonistic autoantibody to the angiotensin II type I receptor |
| Q36537709 | RAS in Pregnancy and Preeclampsia and Eclampsia |
| Q35707881 | Receptor-activating autoantibodies and disease: preeclampsia and beyond |
| Q35743816 | Renin angiotensin signaling in normal pregnancy and preeclampsia |
| Q33591058 | The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia |
| Q37039872 | The functional role of the renin-angiotensin system in pregnancy and preeclampsia |
| Q36467563 | The role of RAS in the pathogenesis of preeclampsia |
| Q46894674 | Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders |
| Q38124456 | Vascular dysfunction in preeclampsia |